A public-private partnership between ARPA-H and VentureWell in support of the ARPANET-H nationwide health innovation network. Website is maintained by VentureWell staff.
The Investor Catalyst Hub recently issued a network survey to gather insights from medical technology developers and manufacturers, healthcare providers, payors, and other key stakeholders about the typical pathways, exemplars, and specific challenges facing medical devices seeking reimbursement. The survey is in support of a new effort by the Advanced Research Projects Agency for Health (ARPA-H) to understand better the reimbursement process for novel medical devices and diagnostics.
The survey findings will help inform ARPA-H of opportunities to deploy best-in-class services to support funding recipients and accelerate the reimbursement of promising medical solutions.
This information session is geared toward individuals, organizations, and companies interested in participating in the network survey. Dr. Arunan Skandarajah, ARPA-H’s Project Accelerator Transition Innovation Office Scientific Operations Advisor, will provide additional insight into the purpose and goals of the survey. Time will be reserved for Q&A.